Jørgen Bjerggaard (@JBjerggaard) header
Jørgen Bjerggaard (@JBjerggaard) profile picture

Jørgen Bjerggaard

@JBjerggaard
Joined August 2015
  • Tweets132
  • Following73
  • Followers108
4Media
Photo by Jørgen Bjerggaard (@JBjerggaard)Photo by Jørgen Bjerggaard (@JBjerggaard)Photo by Jørgen Bjerggaard (@JBjerggaard)Photo by Jørgen Bjerggaard (@JBjerggaard)
Jørgen Bjerggaard retweeted
Tom Powles (@tompowles1) profile picture
Tom Powles
@tompowles15 Sep 2024
urothelial cancer highlight #ESMO24 New ADC data (1st line DV/pembo, EGFR/HER3),TAR200 (pretzel) in MIBC (SUNRISE4), EV/pembro biomarkers (EV302), adjuvant (TOMBOLA) and neoadjuvant (VOLGA) ctDNA, updates on adjuvant pembro (AMBASSADOR), neoadjuvant chemo +/- durvalumab (NIAGRA)
23
1
79
7,829
#ESMO24 - Tombola trial - Serial measurements of cDNA following NAC and RC is a highly specific method to identify patients that might benefit from early immunotherapy at a time of minimal metastatic disease
Image from Diane Delattre, MD, PhD (@DrDelattre)
Image from Diane Delattre, MD, PhD (@DrDelattre)
1
2
243
Jørgen Bjerggaard retweeted
Lars Dyrskjøt (@LDyrskjot) profile picture
Lars Dyrskjøt@LDyrskjot16 Sep 2024
Exited to share the first results from the TOMBOLA trial presented at #ESMO24 by @JBjerggaard. We used tumor informed (WES; ddPCR) ctDNA analysis to guide Atezolizumab treatment after cystectomy using longitudinally collected blood samples. Key findings: •CtDNA-negative patients: 98% RFS at 1 year •~50% are ctDNA-positive •CtDNA-positive patients: 75% RFS at 1 year •55% of Atezolizumab-treated patients cleared ctDNA & have no evidence of disease Conclusion: ctDNA shows promise for treatment de-escalation (ctDNA-) and patient selection for adjuvant therapy (ctDNA+) @Karin_Dem @IverNordentoft @SiaLindskrog @TrineStrandgaa1 @cancer_dk @DCCCcancer @CtdnaDK @AUHdk @AarhusUni
Image from Lars Dyrskjøt (@LDyrskjot)
Image from Lars Dyrskjøt (@LDyrskjot)
Image from Lars Dyrskjøt (@LDyrskjot)
Image from Lars Dyrskjøt (@LDyrskjot)
12
40
2
98
7,184
60 years ago first #renal_transplant performed in Aarhus #AUHdk #urology
Image from Yazan F. Rawashdeh (@YankeeAlphaZulu)
2
14
559
Thank you to all the Faculty for a very successful 7th edition of Rapid Fire Debates in #BladderCancer #EAU2024 #EAU24 @MRoupret @spsutkaMD @AndreaNecchi @joanfundi @evacomperat @SpiessPhilippe @BenjaminPradere @JBjerggaard @AlisonBirtle @MarekBabjuk @paolo_gontero @JimCatto @pcvblack @AStenzl
Image from Ashish M. Kamat, MD, MBBS (@UroDocAsh)
2
12
58
4,129
Pleasure to have you here in Aarhus @ParamMariappan 🦈👍
Prof Param Mariappan FRCS(Urol), PhD (@ParamMariappan) profile pictureProf Param Mariappan FRCS(Urol), PhD@ParamMariappan2 Apr 2024
Many thanks for the kind invitation @AarhusUni_int to examine for the PhD. Great hospitality Jorgen, @LDyrskjot and team - was a pleasure! See you at #EAU24.
Image from Prof Param Mariappan FRCS(Urol), PhD (@ParamMariappan)
Image from Prof Param Mariappan FRCS(Urol), PhD (@ParamMariappan)
Image from Prof Param Mariappan FRCS(Urol), PhD (@ParamMariappan)
2
205
Many thanks for the kind invitation @AarhusUni_int to examine for the PhD. Great hospitality Jorgen, @LDyrskjot and team - was a pleasure! See you at #EAU24.
Image from Prof Param Mariappan FRCS(Urol), PhD (@ParamMariappan)
Image from Prof Param Mariappan FRCS(Urol), PhD (@ParamMariappan)
Image from Prof Param Mariappan FRCS(Urol), PhD (@ParamMariappan)
1
1
12
1,026
Join us April 5th for the 7th edition of Rapid Fire Debates in #BladderCancer #EAU2024 #EAU24 @MRoupret @spsutkaMD @AndreaNecchi @joanfundi @evacomperat @SpiessPhilippe @BenjaminPradere @JBjerggaard @AlisonBirtle @MarekBabjuk @paolo_gontero @JimCatto @pcvblack @AStenzl @Uroweb #OncSurgery
Image from Ashish M. Kamat, MD, MBBS (@UroDocAsh)
2
29
1
91
20,495
Kom maj, du søde milde… Følg med på turen på FB og Instagram blacrest.com/opvarmfod/
2
63
New special edition coming up: Treatment of Bladder Cancer: From Past to Future mdpi.com/si/191676 #mdpijcm via @JCM_MDPI
Treatment of Bladder Cancer: From Past to Future | JCM | MDPI

Treatment of Bladder Cancer: From Past to Future | JCM | MDPI

Bladder cancer is a frequent cancer type with a high degree of diversity regarding its prognosis and treatment modalities. The incidence of bladder cancer has...

mdpi.com
1
60
Preliminary data from our RCT in urinary diversion following radical #cystectomy in #bladdercancer sciencedirect.com/science/ar…
1
47
Min uundværlige sekretær udbygger familien lidt, så der er mulighed for at prøve kræfter med at arbejde i verdens bedste forskningsenhed - med en utrolig flink chef.. Hvis nogen vil høre mere eller søge jobbet, så send dem endelig denne vej:-) midtjob.dk/ad/professorsekre…
1
66
Jørgen Bjerggaard retweeted
Cancers MDPI (@Cancers_MDPI) profile picture
Cancers MDPI@Cancers_MDPI13 Jul 2023
💬Happy to share the Special Issue "Time for a Paradigm Shift in Non-Muscle-Invasive Bladder Cancer (Volume II)" edited by Prof. Dr. Jørgen Bjerggaard J. @JBjerggaard @AarhusUni_int❗️👏 ⏰Deadline for manuscript submissions: 20 March 2024. 🔗Find out more: mdpi.com/journal/cancers/spe…
Image from Cancers MDPI (@Cancers_MDPI)
1
1
284
Jørgen Bjerggaard retweeted
Aarhus Uni.hospital (@AUHdk) profile picture
Aarhus Uni.hospital@AUHdk29 Jan 2023
Tillykke til overlæge og professor Jørgen Bjerggard Jensen på Urinvejskirurgi, som i år løber med JCD-prisen for at være en særligt engageret og dygtig ph.d.-vejleder på @HealthAarhusUni health.au.dk/display/artikel… #forskning #phd #dkvid #dkforsk
Frømand eller forsker? Her er årets ph.d.-vejleder

Frømand eller forsker? Her er årets ph.d.-vejleder

Professor Jørgen Bjerggaard Jensen fra Institut for Klinisk Medicin får JCD-prisen 2023. Han har med sin unikke tilgang og rekrutteringsmodel inspireret af militæret skabt et helt særligt sammenhold...

health.au.dk
3
17
2,093
Jørgen Bjerggaard retweeted
Scand. Assoc. Urol. (@ScandUrol) profile picture
Scand. Assoc. Urol.@ScandUrol28 Apr 2023
Antibiotics may be reduced during follow-up for NMIBC. Thomas Dreyer from Denmark presenting at #AUA2023 in Chicago @JBjerggaard @NessnAzawi @nuf2023 @Uroweb
Image from Scand. Assoc. Urol. (@ScandUrol)
1
2
7
578
The Rapid Fire Debate #Team #EAU23 #BladderCancer @MarekBabjuk @joanfundi @paolo_gontero @slernerbcmedu1 @UrogerliMD @MRoupret @LAUrology_NL @ParamMariappan @JBjerggaard @JimCatto @amassonlecomte @DrShariat @AndreaNecchi @AStenzl @Uroweb
Image from Ashish M. Kamat, MD, MBBS (@UroDocAsh)
3
9
53
3,704
Join us at #EAU23 for our Rapid Fire Debate #BladderCancer Session Sat, March 11, 3:15 pm @MarekBabjuk @joanfundi @paolo_gontero @slernerbcmedu1 @UrogerliMD @MRoupret @LAUrology_NL @ParamMariappan @JBjerggaard @JimCatto @amassonlecomte @DrShariat @AndreaNecchi @AStenzl @Uroweb
Image from Ashish M. Kamat, MD, MBBS (@UroDocAsh)
Image from Ashish M. Kamat, MD, MBBS (@UroDocAsh)
3
21
3
74
21,992
Image from Jørgen Bjerggaard (@JBjerggaard)
1
2
6
179
events.au.dk/joergenbjerggaa…
2
43
Jørgen Bjerggaard retweeted
Juan Luis Vásquez (@JLVasquez82) profile picture
Juan Luis Vásquez@JLVasquez8211 Nov 2022
Replying to @EurUrolOncol @ahmostafid @UroDocAsh @joanfundi @JamesJmm23 @JimCatto
Great 📖 #TURBT is often regarded as a beginner surgical procedure. Huge misunderstanding!!! TURBT is the most important step in the management of #bladdercancer. Training and understanding the disease are mandatory in order to improve outcomes @JBjerggaard @SarahBube @doculla – at Budapest, Hungary
3
10
Load more